Autor:	Jeremy N. Rich, Duane Mitchell, Sameer Agnihotri, Kailin Yang
Rok vydání:	2021
Předmět:	Cancer Research IDH1 Oncology business.industry Metabolic enzymes Glioma Cancer research Medicine Cancer Phases of clinical research In patient business medicine.disease
Zdroj:	Nature Cancer. 2:584-586
ISSN:	2662-1347
Popis:	Despite substantial advances in understanding of the molecular features of gliomas, the therapeutic options for these aggressive tumors remain scarce. Rich, Mitchell and colleagues provide their views about a phase 1 clinical trial testing the safety and efficacy of vaccines against cancer expressing mutant metabolic enzyme IDH1 in patients with high-grade glioma.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4790e782cda993e2d0fa09c54d8fb2e0 https://doi.org/10.1038/s43018-021-00228-2 Zobrazit plný text záznamu Full text from SpringerLink